Plant Variety Rights

(PVRs)

Experts in IP Protection for Plant Variety Inventions


Improvement of crop and ornamental species by genetic modification or modern breeding techniques remains a significant area of innovation. A number of IP rights may be suitable for protecting plant inventions, including patents, trade marks, plant Variety Rights (PVRs) and entry on the national list or common catalogue. Our experienced IP specialists are well placed to assist our clients in this area, having a wealth of practical experience.

In Europe, individual plant varieties that are distinct, uniform and stable can be protected either nationally or at European Community level. Separately, European and national patents can be obtained for plants and plant-related inventions which are not restricted to plant varieties per se, although certain plant breeding methods and plants obtained by those methods are excluded from patentability.  Despite the EU’s strict policies on growing genetically modified crops and uncertainty surrounding the use of genetic resources in plant breeding, there is considerable commercial interest in these technical areas and in IP protection for the output of biotech research and classical breeding programs.

Our expert IP team is led by Frances Salisbury, who has a PhD in plant molecular genetics. An expert in this field Frances has completed the official World Intellectual Property Organisation (WIPO) course on Plant Variety Protection under the UPOV Convention.

Read our Plant Variety Rights Law and Practice guide.

Read our blogs

Cell-free systems and the next wave of biomanufacturing IP

Cell-free systems and the next wave of biomanufacturing IP

by Kate Fitzpatrick

Biomanufacturing is undergoing a structural shift. For decades, engineered cells have been the dominant production platforms, but a new paradigm is emerging: cell free systems.

Dr Tim Lu: “We can programme computers. Why can't we do that in biology?”

Dr Tim Lu: “We can programme computers. Why can't we do that in biology?”

by Richard Clegg

Dr Tim Lu is a pioneer in synthetic biology. He and his team are editing immune cells to upgrade the way they detect disease. His method introduces computer logic gate thinking, where cells ...

The Microbiome in Metabolic Health: more than a gut feeling?

The Microbiome in Metabolic Health: more than a gut feeling?

by Annabel Cardno

Metabolic health has traditionally been viewed through the lens of the host: diet, exercise, genetics, hormones and, more recently, pharmacological intervention. However, over the last decade, it has ...

Innovative Diagnostics: Can New Testing Transform Endometriosis Care?

Innovative Diagnostics: Can New Testing Transform Endometriosis Care?

by Frances Salisbury

The BBC covered an encouraging development this week in the diagnosis of endometriosis, a condition that is still all too often characterised by delay, uncertainty, and a reliance on invasive ...

Beyond PROTACs and molecular glues: where next for heterobifunctional drug discovery?

Beyond PROTACs and molecular glues: where next for heterobifunctional drug discovery?

by Annabel Cardno

A broader heterobifunctional tool emerges Targeted protein degradation has rapidly progressed from a conceptual curiosity to one of the most closely watched areas in drug discovery. As discussed in ...

Global considerations for innovators in microbial biostimulants and biocontrol agents

Global considerations for innovators in microbial biostimulants and biocontrol agents

by Ben Tolley

Our recent analysis found that global patent activity in microbial biostimulants and biocontrol agents is surging, with strong growth in both patent applications and granted patents. For a detailed ...

ME Forward Masthead White 2